NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / India News / J&J withdraws vaccine approval request in India, CDSCO says
    Next Article
    J&J withdraws vaccine approval request in India, CDSCO says
    J&J has withdrawn its vaccine approval request in India, the CDSCO said in a statement.

    J&J withdraws vaccine approval request in India, CDSCO says

    By Sagar
    Aug 02, 2021
    08:21 pm

    What's the story

    Johnson & Johnson has withdrawn its proposal seeking an accelerated approval of its COVID-19 vaccine, Janssen, in India, the country's drug regulator said.

    "The firm has informed that they are withdrawing their proposal," the Central Drugs Standard Control Organisation (CDSCO) announced in a note.

    J&J, however, maintains it is still in talks with the Indian government for its vaccine's delivery in India.

    Quote

    'We're in discussions with the Indian government'

    "We are in ongoing discussions with the government of India and are exploring how best to accelerate our ability to deliver our COVID-19 vaccine to India," J&J said in a statement emailed to news agency Reuters.

    Details

    J&J had sought approval for trial in April

    J&J had, in April, sought approval to carry out a bridging clinical trial of its vaccine in India.

    Reports also said a limited supply of the vaccine could arrive in India in July.

    Janssen is a single-shot COVID-19 vaccine, currently approved in several countries.

    The company recently claimed the jab is effective against the highly-contagious Delta variant and other strains of the coronavirus.

    Controversies

    J&J vaccine has been mired in controversies

    J&J's vaccine was authorized for emergency use in the US this February.

    However, weeks after that, the jab was linked to a rare but serious blood clotting disorder, leading to a brief pause in its use.

    Besides that, in July, the European medicines regulator added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible side effect of the vaccine.

    Vaccines

    Which vaccines are approved in India?

    India had approved Covishield, developed by Oxford-AstraZeneca, and the indigenous jab COVAXIN, in January.

    In April, Russian vaccine Sputnik V was approved by the Indian authorities, however, its supplies remain limited.

    Most recently, American firm Moderna's COVID-19 vaccine became the fourth shot to get the nod in India. But its doses have not arrived in the country yet.

    Vaccination

    How is India's vaccination drive going?

    India has administered more than 47 crore vaccine doses so far.

    Even though nearly 27% of the population have received at least one shot, just around 7.5% have been fully vaccinated.

    India has set a goal of inoculating nearly a billion people by the end of this year.

    However, several states continue to report a shortage of vaccines.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Johnson & Johnson
    Central Drugs Standard Control Organization (CDSCO)
    Coronavirus
    COVID-19 Vaccine

    Latest

    Disha Vakani, Sana Khan: Actors who left TV TV News
    Google just gave Android phones new features to thwart scammers Google
    Gemini AI is coming to everything—including your TV and car Android Auto
    Google announces Wear OS 6 with Gemini AI, new design Android

    Johnson & Johnson

    Johnson & Johnson buying Swiss biotech firm Actelion for $30bn United States of America
    Johnson & Johnson to pay $110mn over talcum cancer-link Cancer
    Artificial intelligence will aid in inventing drugs faster: Pharma companies Health & Wellness
    Mumbai battles tuberculosis: 50,000 cases reported in 3 years Mumbai

    Central Drugs Standard Control Organization (CDSCO)

    Bengaluru Lake Frothing: Centre seeks CPCB's response over phosphorus pollution Climate Change
    Health Ministry bans sale of 14 steroid-creams sans doctor's prescription Ministry of Health and Family Welfare
    Government plans to make companies responsible for drug regulation violations India
    Health Ministry to rename drug regulator CDSCO; invites suggestions India

    Coronavirus

    Coronavirus: India reports 38K+ new cases; 60% in Kerala, Maharashtra Maharashtra
    Azithromycin no more effective against COVID-19 than placebo: Study COVID-19
    Gujarat: Over 200 people gather for religious event; FIR filed Gujarat
    Norovirus outbreak reported in the UK. What is it? England

    COVID-19 Vaccine

    Three million Sputnik V doses reach Hyderabad from Russia Hyderabad
    Mumbai: No jabs for most students headed to foreign shores Mumbai
    Centre enters deal with Biological E for 30cr vaccine doses Ministry of Health and Family Welfare
    Deck cleared for import of COVAXIN, Sputnik V into Brazil Brazil
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025